Preventive Effects of Echinacea Extract on Upper Respiratory Infections – International Buyers' Preferred Standardized Extraction Solutions

2025-07-06 12:32

**Title: Preventive Effects of Echinacea Extract on Upper Respiratory Infections – International Buyers' Preferred Standardized Extraction Solutions**   

IMG_20250706_112535.png

Introduction

Echinacea purpurea extract has been widely studied for its immune-enhancing properties, particularly in preventing upper respiratory tract infections (URTIs). As a leading B2B supplier, **Blue Eyes Biotech Co., Ltd** provides standardized Echinacea extracts (≥4% cichoric acid, ≥0.5% alkylamides) with clinically validated efficacy for global nutraceutical and pharmaceutical applications. This paper reviews key clinical evidence and presents an optimized extraction protocol for maximum preventive benefits.   

Clinical Evidence for URTI Prevention

1. Meta-Analysis Findings   

   - A 2019 meta-analysis of 14 RCTs showed Echinacea reduced **URTI incidence by 22%** (RR 0.78, 95% CI 0.68–0.88) compared to placebo.   

   - Children taking Echinacea had **35% fewer recurrent respiratory infections** and reduced antibiotic use.   

2. Mechanisms of Action

   - Immune Modulation: Polysaccharides enhance macrophage phagocytosis and NK cell activity.   

   - Antiviral Effects: Alkylamides inhibit viral entry by blocking hemagglutinin in influenza strains.   

3. Human Trial Data

   - A 12-week military study found Echinacea purpurea root extract delayed first URTI onset by 5 days vs. placebo.   

Standardized Extraction Protocol   

- Raw Material: Fresh flowering tops (highest cichoric acid content).   

- Extraction Method: Ethanol-water (55:45) for dual-phase solubility of alkylamides and polysaccharides.   

- Quality Control:   

   - **HPLC standardization**: ≥4% cichoric acid, ≥0.5% alkylamides.   

   - **Microbial safety**: TAMC < 100 CFU/g, endotoxins < 0.1 EU/mg.   

Why Choose Blue Eyes Biotech?

- GMP & ISO-Certified: Batch-to-batch consistency with third-party lab reports.   

- Custom Formulations: Powder (10:1 extract), liquid (glycolic tincture), or capsule-ready.   

- Global Compliance: Meets FDA, EU Pharmacopoeia, and FSSC 22000 standards.   

Contact Us for Premium Echinacea Extracts:   

**Email:** [email protected]   

**Website:** [www.blueeyes-bio.com](http://www.blueeyes-bio.com)   

Conclusion   

Echinacea extract offers significant preventive effects against URTIs through immune modulation and antiviral activity. **Blue Eyes Biotech** delivers **high-potency, research-backed extracts** with optimized bioavailability for global buyers in preventive healthcare.   

---   

*References: Integrated from clinical trials and industry reports.*


Name:
Message:
Verification code:
Submit
Comment